Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Audientes – Presentation of Q3 2024 report

By Michael FriisHead of Equities
Audientes

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

Audientes expects to release its Q3 2024 results on 21 November 2024. Audientes’ CEO Steen Thygesen will present the results, provide a business update, and answer questions at an online live event on 22 November 2024 at 11:00.

Since the H1 2024 report, Audientes has announced news regarding the capital situation and funding journey. The company has agreed with existing lenders to postpone payments of DKK 2.3m into 2025 and a direct issue with both new cash and conversion of debt of DKK 1.7m to deliver on the opportunities the company is experiencing. Additionally, Audientes has also initiated a consumer marketing & sales campaign targeting Japan's large "Silver Market". Besides the financial results, the focus could be on comments about the market launches in Japan and China as well as the capital situation.

Audientes is a Danish hearing health company specializing in smart, self-fitting affordable hearing aids and advanced hearables. Audientes’ unique hearing aid solution, Ven™ by Audientes, is available for purchase in the Indian and Nepalese markets and is expected to be introduced in other markets in the coming years.

Disclaimer: HC Andersen Capital receives payment from Audientes for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 09.07, 4 November 2024.

Recent videos

Oncopeptides, Audiocast, Investor Conference, 2026
16.01.2026 klo 10.00 Oncopeptides
Duell, Webcast, Q1'26
14.01.2026 klo 10.30 Duell
Dustin Group, Audiocast, Q1'26
14.01.2026 klo 10.00 Dustin Group
Herantis Pharma Plc, Phase 1b biomarker data webcast
08.01.2026 klo 12.00 Herantis Pharma
Investor Day | Nov. 24, 2025
23.12.2025 klo 12.00 United Bankers
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.